Inventor

KREILEIN MATTHEW MICHAEL

US13 patents

⚠️ This page may combine multiple inventors who share the name “KREILEIN MATTHEW MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGNAL PHARM LLC

7 patents

US9079900B2Jul 14, 2015

Methods of synthesis and purification of heteroaryl compounds

SIGNAL PHARM LLC5 citations82

US9403829B2Aug 2, 2016

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use

SIGNAL PHARM LLC13 citations81

US9359364B2Jun 7, 2016

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one

SIGNAL PHARM LLC10 citations81

US9604939B2Mar 28, 2017

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use

SIGNAL PHARM LLC1 citations59

US9827243B2Nov 28, 2017

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

SIGNAL PHARM LLC0 citations51

US9974786B2May 22, 2018

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use

SIGNAL PHARM LLC0 citations48

US9795603B2Oct 24, 2017

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use

SIGNAL PHARM LLC0 citations48

CELGENE QUANTICEL RES INC

4 patents

US10316016B2Jun 11, 2019

HARRIS ROY L

1 patent

US8569494B2Oct 29, 2013

Methods of synthesis and purification of heteroaryl compounds

HARRIS ROY L27 citations88

CELGENE CORP

1 patent

US10590136B2Mar 17, 2020

Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide

CELGENE CORP0 citations36

KREILEIN MATTHEW MICHAEL

SIGNAL PHARM LLC

Methods of synthesis and purification of heteroaryl compounds

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use

CELGENE QUANTICEL RES INC

Compositions comprising an inhibitor of lysine specific demethylase-1

Compositions comprising an inhibitor of lysine specific demethylase-1

Compositions comprising an inhibitor of lysine specific demethylase-1

Compositions comprising an inhibitor of lysine specific demethylase-1

HARRIS ROY L

Methods of synthesis and purification of heteroaryl compounds

CELGENE CORP

Processes for the preparation of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide